Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
Sec Filings Insider Trading - Syros Pharmaceuticals Inc. (SYRS)
Select Time period:       google icon google     yahoo icon yahoo!
Send this page to:   blogger icon Blog    digg icon Digg    reddit icon Reddit    facebook icon Facebook    stumble icon Stumble    delicious icon del.icio.us

Enter Stock Ticker Symbol or Cik: SEC Cik Lookup Cik Lookup...

Search By Company or Insider Name: Powered by Google button
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch ==>> What is insider trading>>
SYRS Insider Trading Transactions for Syros Pharmaceuticals Inc.
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
Date
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-08-14
Sale
2017-08-16
4:08 pm
Syros Pharmaceuticals Inc. SYRS Young Richard A
Director
3,282 $22 $72,204 420,101
(Direct)
View
2017-08-07
Sale
2017-08-08
5:20 pm
Syros Pharmaceuticals Inc. SYRS Olson Eric R
Chief Scientific Officer
2,500 $23.59 $58,969 110,075
(Direct)
View
2017-07-25
Sale
2017-07-27
4:09 pm
Syros Pharmaceuticals Inc. SYRS Olson Eric R
Chief Scientific Officer
12,500 $21.85 $273,125 25,025
(Direct)
View
2017-07-25
Sale
2017-07-27
4:09 pm
Syros Pharmaceuticals Inc. SYRS Young Richard A
Director
3,282 $22.09 $72,496 423,383
(Direct)
View
2016-07-06
Purchase
2016-07-07
5:41 pm
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
10% Owner
400,000 $12.5 $5,000,000 1,538,333
(Indirect)
View
2016-07-06
Purchase
2016-07-07
5:41 pm
Syros Pharmaceuticals Inc. SYRS Polaris Management Co. Vii L.L.C.
Polaris Partners Vii L.P.
Polaris Entrepreneurs' Fund Vii L.P.
10% Owner
400,000 $12.5 $5,000,000 1,538,333
(Indirect)
View
2016-07-06
Purchase
2016-07-07
06:04 am
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
400,000 $12.5 $5,000,000 3,674,660
(Indirect)
View
2016-07-06
Purchase
2016-07-07
06:03 am
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
432,746 $12.5 $5,409,325 366,739
(Direct)
View
2016-07-06
Purchase
2016-07-07
06:02 am
Syros Pharmaceuticals Inc. SYRS Arch Venture Fund Vii Lp
Arch Venture Partners Vii L.P.
Arch Venture Partners Vii LLC
Crandell Keith
Bybee Clinton
10% Owner
400,000 $12.5 $5,000,000 4,637,137
(Direct)
View
2016-07-06
Purchase
2016-07-06
9:22 pm
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
400,000 $12.5 $5,000,000 4,637,137
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
Date
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-08-17
Other
2017-08-21
4:19 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
1,295,997 $0 2,378,663
(Direct)
View
2017-08-17
Other
2017-08-21
4:19 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
306,222 $0 2,378,663
(Indirect)
View
2017-08-17
Other
2017-08-21
4:19 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
54,293 $0 2,378,663
(Indirect)
View
2017-08-07
Exercise
2017-08-08
5:20 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Olson Eric R
Chief Scientific Officer
2,500 $1.01 110,075
(Direct)
View
2017-08-07
Exercise
2017-08-08
5:20 pm
N/A
2023-05-22
Syros Pharmaceuticals Inc. SYRS Olson Eric R
Chief Scientific Officer
2,500 $1.01 110,075
(Direct)
View
2017-07-25
Exercise
2017-07-27
4:09 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Olson Eric R
Chief Scientific Officer
12,500 $1.01 25,025
(Direct)
View
2017-07-25
Exercise
2017-07-27
4:09 pm
N/A
2023-05-22
Syros Pharmaceuticals Inc. SYRS Olson Eric R
Chief Scientific Officer
12,500 $1.01 25,025
(Direct)
View
2017-06-08
Option Award
2017-06-12
4:04 pm
N/A
2027-06-07
Syros Pharmaceuticals Inc. SYRS Akkaraju Srinivas
Director
22,000 $14.26 22,000
(Direct)
View
2017-06-08
Option Award
2017-06-12
4:04 pm
N/A
2027-06-07
Syros Pharmaceuticals Inc. SYRS Fanucci Marsha
Director
11,000 $14.26 11,000
(Direct)
View
2017-06-08
Option Award
2017-06-12
4:03 pm
N/A
2027-06-07
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
11,000 $14.26 11,000
(Direct)
View
2017-06-08
Option Award
2017-06-12
4:03 pm
N/A
2027-06-07
Syros Pharmaceuticals Inc. SYRS Patel Sanj K
Director
11,000 $14.26 11,000
(Direct)
View
2017-06-08
Option Award
2017-06-12
4:03 pm
N/A
2027-06-07
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
11,000 $14.26 11,000
(Direct)
View
2017-06-08
Option Award
2017-06-12
4:03 pm
N/A
2027-06-07
Syros Pharmaceuticals Inc. SYRS Sato Vicki L
Director
11,000 $14.26 11,000
(Direct)
View
2017-06-08
Option Award
2017-06-12
4:02 pm
N/A
2027-06-07
Syros Pharmaceuticals Inc. SYRS Sharp Philip A
Director
11,000 $14.26 11,000
(Direct)
View
2017-06-08
Option Award
2017-06-12
4:02 pm
N/A
2027-06-07
Syros Pharmaceuticals Inc. SYRS Young Richard A
Director
11,000 $14.26 11,000
(Direct)
View
2017-02-10
Option Award
2017-02-13
5:17 pm
N/A
2027-02-09
Syros Pharmaceuticals Inc. SYRS Kuvalanka Kyle D.
Chief Operating Officer
78,000 $10.9 78,000
(Direct)
View
2017-02-10
Option Award
2017-02-13
5:17 pm
N/A
2027-02-09
Syros Pharmaceuticals Inc. SYRS Simonian Nancy A
President & CEO
Director
175,000 $10.9 175,000
(Direct)
View
2017-02-10
Option Award
2017-02-13
5:16 pm
N/A
2027-02-09
Syros Pharmaceuticals Inc. SYRS Olson Eric R
Chief Scientific Officer
63,500 $10.9 63,500
(Direct)
View
2017-02-10
Option Award
2017-02-13
5:16 pm
N/A
2027-02-09
Syros Pharmaceuticals Inc. SYRS Quirk Gerald E
Chief Legal Officer
40,000 $10.9 40,000
(Direct)
View
2017-02-10
Option Award
2017-02-13
5:16 pm
N/A
2027-02-09
Syros Pharmaceuticals Inc. SYRS Roth David
Chief Medical Officer
63,500 $10.9 63,500
(Direct)
View
2017-01-27
Option Award
2017-01-30
08:42 am
N/A
2027-01-26
Syros Pharmaceuticals Inc. SYRS Wirth Peter
Director
22,000 $10.76 22,000
(Direct)
View
2016-09-27
Option Award
2016-09-29
5:11 pm
N/A
2026-09-26
Syros Pharmaceuticals Inc. SYRS Quirk Gerald E
Chief Legal Officer
105,000 $13.3 105,000
(Direct)
View
2016-09-16
Option Award
2016-09-19
06:59 am
N/A
2026-09-15
Syros Pharmaceuticals Inc. SYRS Simonian Nancy A
President & CEO
Director
75,000 $12.17 75,000
(Direct)
View
2016-09-15
Option Award
2016-09-19
06:57 am
N/A
2026-09-14
Syros Pharmaceuticals Inc. SYRS Sato Vicki L
Director
22,000 $12.59 22,000
(Direct)
View
2016-09-15
Option Award
2016-09-19
06:57 am
N/A
2026-09-14
Syros Pharmaceuticals Inc. SYRS Patel Sanj K
Director
22,000 $12.59 22,000
(Direct)
View
2016-09-15
Option Award
2016-09-19
06:56 am
N/A
2026-09-14
Syros Pharmaceuticals Inc. SYRS Sharp Philip A
Director
22,000 $12.59 22,000
(Direct)
View
2016-09-15
Option Award
2016-09-19
06:56 am
N/A
2026-09-14
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
10% Owner
22,000 $12.59 22,000
(Direct)
View
2016-09-15
Option Award
2016-09-19
06:55 am
N/A
2026-09-14
Syros Pharmaceuticals Inc. SYRS Bancel Stephane
Director
22,000 $12.59 22,000
(Direct)
View
2016-09-15
Option Award
2016-09-19
06:55 am
N/A
2026-09-14
Syros Pharmaceuticals Inc. SYRS Young Richard A
Director
22,000 $12.59 22,000
(Direct)
View
2016-09-15
Option Award
2016-09-19
06:54 am
N/A
2026-09-14
Syros Pharmaceuticals Inc. SYRS Fanucci Marsha
Director
22,000 $12.59 22,000
(Direct)
View
2016-09-15
Option Award
2016-09-19
06:54 am
N/A
2026-09-14
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
22,000 $12.59 22,000
(Direct)
View
2016-07-06
Conversion
2016-07-07
5:41 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
10% Owner
1,164,486 $0 1,538,333
(Indirect)
View
2016-07-06
Conversion
2016-07-07
5:41 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
10% Owner
22,167 $0 1,538,333
(Indirect)
View
2016-07-06
Conversion
2016-07-07
5:41 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
10% Owner
4,366,825 $0 1,538,333
(Indirect)
View
2016-07-06
Conversion
2016-07-07
5:41 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nashat Amir
Director
10% Owner
83,129 $0 1,538,333
(Indirect)
View
2016-07-06
Conversion
2016-07-07
5:41 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Polaris Management Co. Vii L.L.C.
Polaris Partners Vii L.P.
Polaris Entrepreneurs' Fund Vii L.P.
10% Owner
1,164,486 $0 1,538,333
(Indirect)
View
2016-07-06
Conversion
2016-07-07
5:41 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Polaris Management Co. Vii L.L.C.
Polaris Partners Vii L.P.
Polaris Entrepreneurs' Fund Vii L.P.
10% Owner
22,167 $0 1,538,333
(Indirect)
View
2016-07-06
Conversion
2016-07-07
5:41 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Polaris Management Co. Vii L.L.C.
Polaris Partners Vii L.P.
Polaris Entrepreneurs' Fund Vii L.P.
10% Owner
4,366,825 $0 1,538,333
(Indirect)
View
2016-07-06
Conversion
2016-07-07
5:41 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Polaris Management Co. Vii L.L.C.
Polaris Partners Vii L.P.
Polaris Entrepreneurs' Fund Vii L.P.
10% Owner
83,129 $0 1,538,333
(Indirect)
View
2016-07-06
Conversion
2016-07-07
08:15 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Wuxi Pharmtech Healthcare Fund I L.P.
10% Owner
133,333 $0 931,857
(Direct)
View
2016-07-06
Conversion
2016-07-07
08:15 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Wuxi Pharmtech Healthcare Fund I L.P.
10% Owner
133,333 $0 931,857
(Direct)
View
2016-07-06
Conversion
2016-07-07
08:15 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Wuxi Pharmtech Healthcare Fund I L.P.
10% Owner
133,333 $0 931,857
(Direct)
View
2016-07-06
Conversion
2016-07-07
08:15 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Wuxi Pharmtech Healthcare Fund I L.P.
10% Owner
531,858 $0 931,857
(Direct)
View
2016-07-06
Conversion
2016-07-07
08:15 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Wuxi Pharmtech Healthcare Fund I L.P.
10% Owner
500,000 $0 931,857
(Direct)
View
2016-07-06
Conversion
2016-07-07
08:15 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Wuxi Pharmtech Healthcare Fund I L.P.
10% Owner
500,000 $0 931,857
(Direct)
View
2016-07-06
Conversion
2016-07-07
08:15 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Wuxi Pharmtech Healthcare Fund I L.P.
10% Owner
500,000 $0 931,857
(Direct)
View
2016-07-06
Conversion
2016-07-07
08:15 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Wuxi Pharmtech Healthcare Fund I L.P.
10% Owner
1,994,471 $0 931,857
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
213,333 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
53,333 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
1,066,666 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
266,666 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
1,600,000 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
400,000 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
474,661 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
118,665 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
800,000 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
200,000 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
4,000,000 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
1,000,000 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
6,000,000 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
1,500,000 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
1,779,981 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:04 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Flagship Ventures Fund Iv L.P.
Flagship Ventures Fund Iv-rx L.P.
Flagship Venturelabs Iv LLC
Flagship Ventures Fund Iv General Partner LLC
Afeyan Noubar
Kania Edwin M Jr
10% Owner
444,995 $0 3,674,660
(Indirect)
View
2016-07-06
Conversion
2016-07-07
06:03 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
84,760 $0 366,739
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:03 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
47,486 $0 366,739
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:03 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
262,069 $0 366,739
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:03 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
31,447 $0 366,739
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:03 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
40,420 $0 366,739
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:03 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
317,853 $0 366,739
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:03 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
178,074 $0 366,739
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:03 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
982,762 $0 366,739
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:03 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
117,931 $0 366,739
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:03 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Redmile Group LLC
Green Jeremy
10% Owner
151,576 $0 366,739
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:02 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Arch Venture Fund Vii Lp
Arch Venture Partners Vii L.P.
Arch Venture Partners Vii LLC
Crandell Keith
Bybee Clinton
10% Owner
266,666 $0 4,637,137
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:02 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Arch Venture Fund Vii Lp
Arch Venture Partners Vii L.P.
Arch Venture Partners Vii LLC
Crandell Keith
Bybee Clinton
10% Owner
1,333,333 $0 4,637,137
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:02 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Arch Venture Fund Vii Lp
Arch Venture Partners Vii L.P.
Arch Venture Partners Vii LLC
Crandell Keith
Bybee Clinton
10% Owner
2,000,000 $0 4,637,137
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:02 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Arch Venture Fund Vii Lp
Arch Venture Partners Vii L.P.
Arch Venture Partners Vii LLC
Crandell Keith
Bybee Clinton
10% Owner
423,805 $0 4,637,137
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:02 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Arch Venture Fund Vii Lp
Arch Venture Partners Vii L.P.
Arch Venture Partners Vii LLC
Crandell Keith
Bybee Clinton
10% Owner
1,000,000 $0 4,637,137
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:02 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Arch Venture Fund Vii Lp
Arch Venture Partners Vii L.P.
Arch Venture Partners Vii LLC
Crandell Keith
Bybee Clinton
10% Owner
5,000,000 $0 4,637,137
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:02 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Arch Venture Fund Vii Lp
Arch Venture Partners Vii L.P.
Arch Venture Partners Vii LLC
Crandell Keith
Bybee Clinton
10% Owner
7,500,000 $0 4,637,137
(Direct)
View
2016-07-06
Conversion
2016-07-07
06:02 am
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Arch Venture Fund Vii Lp
Arch Venture Partners Vii L.P.
Arch Venture Partners Vii LLC
Crandell Keith
Bybee Clinton
10% Owner
1,589,269 $0 4,637,137
(Direct)
View
2016-07-06
Conversion
2016-07-06
9:25 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Wuxi Healthcare Ventures II L.P.
10% Owner
423,805 $0 423,805
(Direct)
View
2016-07-06
Conversion
2016-07-06
9:25 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Wuxi Healthcare Ventures II L.P.
10% Owner
1,589,269 $0 423,805
(Direct)
View
2016-07-06
Conversion
2016-07-06
9:24 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Bancel Stephane
Director
26,666 $0 47,980
(Direct)
View
2016-07-06
Conversion
2016-07-06
9:24 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Bancel Stephane
Director
100,000 $0 47,980
(Direct)
View
2016-07-06
Conversion
2016-07-06
9:23 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Sharp Philip A
Director
146,666 $0 146,666
(Direct)
View
2016-07-06
Conversion
2016-07-06
9:23 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Sharp Philip A
Director
40,000 $0 146,666
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:23 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Sharp Philip A
Director
40,000 $0 146,666
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:23 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Sharp Philip A
Director
40,000 $0 146,666
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:23 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Sharp Philip A
Director
550,000 $0 146,666
(Direct)
View
2016-07-06
Conversion
2016-07-06
9:23 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Sharp Philip A
Director
150,000 $0 146,666
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:23 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Sharp Philip A
Director
150,000 $0 146,666
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:23 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Sharp Philip A
Director
150,000 $0 146,666
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:23 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Simonian Nancy A
President and CEO
Director
66,666 $0 370,702
(Direct)
View
2016-07-06
Conversion
2016-07-06
9:23 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Simonian Nancy A
President and CEO
Director
250,000 $0 370,702
(Direct)
View
2016-07-06
Conversion
2016-07-06
9:22 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
266,666 $0 4,637,137
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:22 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
1,333,333 $0 4,637,137
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:22 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
2,000,000 $0 4,637,137
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:22 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
423,805 $0 4,637,137
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:22 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
1,000,000 $0 4,637,137
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:22 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
5,000,000 $0 4,637,137
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:22 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
7,500,000 $0 4,637,137
(Indirect)
View
2016-07-06
Conversion
2016-07-06
9:22 pm
N/A
N/A
Syros Pharmaceuticals Inc. SYRS Nelsen Robert
Director
10% Owner
1,589,269 $0 4,637,137
(Indirect)
View
Goto page 0, 1, Next